Is GE HealthCare Technologies Inc. (GEHC) a Buy, Sell, or Hold?
GE HealthCare Technologies Inc.
NASDAQ:GEHC
$63.57 USD
$1.91 (3.1%)
- Volume
- 2.92M
- Average Volume
- 5.23M
- Market Capitalization
- $28.92B
- P/E Ratio
- 19.26
- Dividend Yield
- 0.22%
- Price Target
- $80.00
- Year High
- $89.77
- Year Low
- $58.75
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.04
- Current Ratio
- $1.17
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Peter J. Arduini |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Current Symbol | GEHC |
| CUSIP | 36266G107 |
| CIK | 0001932393 |
| Web | https://www.gehealthcare.com |
| Phone | 833 735 1139 |
| Currency | USD |
| Employees | 54000 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.99 |
| Payout Ratio | 0.04 |
| Current Ratio | 1.17 |
| Quick Ratio | 0.89 |
| Cash Ratio | 0.27 |
Sales & Book Value
| Annual Sales | $20.62B |
| Price / Sales | 1.45 |
| Cash Flow | 3.33 |
| Price / Cash Flow | 19.02 |
| Price / Book | 2.72 |
Price Target and Rating
| Average Stock Price Forecast | $80.00 |
| High Stock Price Forecast | $90.00 |
| Low Stock Price Forecast | $65.00 |
| Forecast Upside/Downside | -20.54% |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 18 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $4.55 |
| Trailing P/E Ratio | 19.26 |
| PEG Ratio | -0.62 |
| P/E Growth | -0.62 |
| Net Income | $2.08B |
| Net Margin | 7.54% |
| Pretax Margin | 9.84% |
| Return on Equity | 14.77% |
| Return on Assets | 4.05% |
Financials Score
| AltmanZ Score | 1.69 |
| Piotroski Score | 6.00 |
| Working Capital | 1.45B |
| Total Assets | 37.12B |
| Ebit | 2.4B |
| Market Cap | 29.71B |
| Total Liabilities | 26.23B |
Poll Results
About GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magneti ... c Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
Do Options Traders Know Something About GE HealthCare Stock We Don't?
2026-07-14 11:51:08
Investors need to pay close attention to GEHC stock based on the movements in the options market lately.
GE HealthCare & Mayo Clinic Unite to Advance Cancer Theranostics
2026-07-09 14:37:04
GEHC and Mayo Clinic collaboration aims to advance adaptive cancer theranostics using imaging, biomarkers and clinical data from the MI-BET study.
2026-07-08 15:00:00
LOS ANGELES, July 8, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ: GEHC) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC.
2026-07-08 09:00:00
BENSALEM, Pa., July 8, 2026 /PRNewswire/ -- Law Offices of Howard G.
2026-07-08 09:00:00
CHICAGO & ROCHESTER, Minn.--(BUSINESS WIRE)--GE HealthCare and Mayo Clinic today announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research collaboration, a novel theranostics study designed to explore a more personalized approach to radioligand therapy (RLT) for patients with advanced prostate cancer. This collaboration is a direct result of the 2023 Strategic Radiology Research Alliance between Mayo Clinic and GE HealthCare, aimed at transforming the experience of.
GE HealthCare to announce second quarter 2026 results on July 29, 2026
2026-07-08 08:00:00
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will.
2026-07-07 19:25:00
LOS ANGELES, July 7, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz continues its investigation of GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ: GEHC) on behalf of investors concerning the Company's possible violations of federal securities laws.
GE HealthCare announces cash dividend for second quarter of 2026
2026-06-30 14:20:00
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2026 payable on August 14, 2026, to all shareholders of record as of July 24, 2026.About GE HealthCare Technologies Inc.GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle.
Frequently Asked Questions
-
What is the current GE HealthCare Technologies Inc. (GEHC) stock price?
-
GE HealthCare Technologies Inc.(NASDAQ:GEHC) stock price is $63.57 in the last trading session. During the trading session, GEHC stock reached the peak price of $89.77 while $58.75 was the lowest point it dropped to. The percentage change in GEHC stock occurred in the recent session was 3.1% while the dollar amount for the price change in GEHC stock was $1.91.
-
GEHC's industry and sector of operation?
-
The NASDAQ listed GEHC is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of GEHC?
-
Jahid Khandaker | Chief Information Officer
Rana Strellis | Chief Corporate Marketing & Communications Officer
George Andrew Newcomb | Controller & Chief Accounting Officer
Adam Holton | Chief People Officer
James K. Saccaro | Vice President & Chief Financial Officer -
How many employees does GEHC have?
-
Number of GEHC employees currently stands at 54000. GEHC operates from 500 West Monroe Street, Chicago, IL 60661, US.
-
Link for GEHC official website?
-
Official Website of GEHC is: https://www.gehealthcare.com
-
How do I contact GEHC?
-
GEHC could be contacted at phone #833 735 1139 and can also be accessed through its website. GEHC operates from 500 West Monroe Street, Chicago, IL 60661, US.
-
How many shares of GEHC are traded daily?
-
The average number of GEHC shares traded daily for last 3 months was 5.23M.
-
What is the market cap of GEHC currently?
-
The market value of GEHC currently stands at $28.92B with its latest stock price at $63.57